Decoding microbial-Aryl Hydrocarbon Receptor interactions at the skin barrier interface

解码皮肤屏障界面处的微生物-芳基烃受体相互作用

基本信息

  • 批准号:
    10689803
  • 负责人:
  • 金额:
    $ 9.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY An effective epidermal permeability barrier (EPB) protects the skin from dehydration, inflammation, premature aging, environmental exposure, and infection. Epidermal barrier dysfunction is an important feature of atopic dermatitis, as well as numerous skin diseases including psoriasis, acne, and rosacea. A fundamental and holistic understanding of mechanisms regulating homeostatic barrier function is essential to effectively prevent and manage barrier abnormalities. The EPB function resides in the skin epidermis, which is home to diverse microbial communities. The microbiome is recognized as a functional unit of the skin barrier. The skin ecosystem is continuously challenged by the external exposome that includes ultraviolet radiation (UVR), air pollutants and allergens. Critical for the barrier defense and homeostasis are xenobiotic sensors that recognize external signals and help identify beneficial (e.g., commensal microbes) from harmful (e.g., pollutants, pathogens) xenobiotics to regulate barrier defenses. Recently, I have demonstrated that commensal microbes regulate epidermal differentiation and barrier permeability of the skin by activating xenobiotic sensor, the aryl hydrocarbon receptor (AHR). However, the mechanisms by which commensal microbes regulate EPB through AHR under homeostasis, and in presence of environmental insults such as UVR are unexplored. The central hypothesis of this proposal is that tuning of epithelial responses by modulating AHR-commensal interactions can alter barrier permeability. This project utilizes ‘multi-omics’ approaches by integrating transcriptomics, metagenomics, and metabolomics to understand host-microbiota interactions in skin barrier repair. In Aim 1, I will identify microbial signals from a synthetic commensal community that can activate AHR. These studies will lead to identification of microbial ligands that can be used to target AHR in barrier diseases. In Aim 2, I will test contributions of commensal microbiome in protecting against UV-induced barrier damage and use multiomics approaches to characterize microbiome-host-UV interactome in the context of AHR signaling. These studies will provide a framework to generate therapies that leverage understanding of environmental-host-microbiome interactions. During the K99 phase, I will be trained in metabolomics to identify microbial metabolites. I will receive advanced training in bioinformatics and systems biology approaches that focus on integrating multiple omics datasets. The outstanding training environment at the University of Pennsylvania coupled with the excellent advisory committee I have assembled, will greatly facilitate my research during the mentored phase as well as launch my career with the skills necessary for understanding the role of the microbiome-host- environment interactome in regulating skin barrier repair.
项目概要 有效的表皮渗透屏障(EPB)可保护皮肤免受脱水、炎症、早产的影响 衰老、环境暴露和感染。表皮屏障功能障碍是特应性皮肤病的一个重要特征 皮炎,以及许多皮肤病,包括牛皮癣、痤疮和红斑痤疮。一个基本的和 全面了解调节稳态屏障功能的机制对于有效预防 并管理屏障异常。 EPB 功能位于皮肤表皮,是多种细胞的所在地。 微生物群落。微生物组被认为是皮肤屏障的功能单位。皮肤 生态系统不断受到外部暴露的挑战,包括紫外线辐射(UVR)、空气 污染物和过敏原。对于屏障防御和体内平衡至关重要的是能够识别的外源传感器 外部信号并帮助识别有益(例如共生微生物)和有害(例如污染物、 病原体)异生素来调节屏障防御。最近,我证明了共生微生物 通过激活异生传感器芳基来调节表皮分化和皮肤屏障通透性 碳氢化合物受体(AHR)。然而,共生微生物通过调节 EPB 的机制 稳态下以及紫外线等环境损害下的 AHR 尚未被探索。中央 该提议的假设是通过调节 AHR 共生相互作用来调整上皮反应 可以改变屏障的渗透性。该项目通过整合转录组学来利用“多组学”方法, 宏基因组学和代谢组学,以了解皮肤屏障修复中宿主-微生物群的相互作用。在目标 1 中,我 将识别来自合成共生群落的微生物信号,这些信号可以激活 AHR。这些研究将 导致鉴定可用于针对屏障疾病中的 AHR 的微生物配体。在目标 2 中,我将测试 共生微生物组在防止紫外线引起的屏障损伤方面的贡献并使用多组学 在 AHR 信号传导背景下表征微生物组-宿主-UV 相互作用组的方法。这些研究 将提供一个框架来产生利用对环境-宿主-微生物组的理解的疗法 互动。在 K99 阶段,我将接受代谢组学方面的培训,以识别微生物代谢物。我会 接受生物信息学和系统生物学方法的高级培训,重点关注整合多种方法 组学数据集。宾夕法尼亚大学优越的培养环境加上 我组建的优秀顾问委员会将极大地促进我在指导阶段的研究 以及以了解微生物组-宿主-的作用所需的技能开始我的职业生涯 环境相互作用组调节皮肤屏障修复。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cutibacterium acnes evolution: One pore at a time.
痤疮皮肤杆菌进化:一次一个毛孔。
  • DOI:
    10.1016/j.chom.2022.01.007
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    30.3
  • 作者:
    Flowers,Laurice;Campbell,Amy;Uberoi,Aayushi
  • 通讯作者:
    Uberoi,Aayushi
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AAYUSHI UBEROI其他文献

AAYUSHI UBEROI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AAYUSHI UBEROI', 18)}}的其他基金

Decoding microbial-Aryl Hydrocarbon Receptor interactions at the skin barrier interface
解码皮肤屏障界面处的微生物-芳基烃受体相互作用
  • 批准号:
    10507321
  • 财政年份:
    2022
  • 资助金额:
    $ 9.06万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.06万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.06万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.06万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 9.06万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 9.06万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 9.06万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 9.06万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 9.06万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 9.06万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 9.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了